José de la Fuente Selected Research

José de la Fuente Research Topics

Disease

90	Infections 01/2024 - 05/2002
58	Tick Infestations 04/2024 - 03/2003
25	Tick-Borne Diseases (Tick-Borne Disease) 04/2024 - 12/2008
23	Anaplasmosis 11/2022 - 07/2002
16	Hypersensitivity (Allergy) 12/2023 - 10/2015
16	Tick Bites 01/2023 - 10/2015
15	red meat allergy 12/2023 - 01/2018
15	Communicable Diseases (Infectious Diseases) 02/2023 - 11/2009
12	COVID-19 02/2023 - 01/2020
11	Anaphylaxis (Anaphylactic Shock) 01/2023 - 03/2017
10	Tuberculosis (Tuberculoses) 01/2023 - 01/2007
5	Inflammation (Inflammations) 10/2023 - 03/2006
5	Malaria 04/2021 - 12/2014
4	Lyme Disease (Disease, Lyme) 01/2021 - 05/2005
4	Vector Borne Diseases 07/2019 - 03/2013
4	Bacterial Infections (Bacterial Infection) 07/2016 - 01/2013
3	Babesiosis (Piroplasmosis) 01/2021 - 01/2015
3	Bovine Tuberculosis 01/2017 - 05/2009
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 02/2023
2	Food Hypersensitivity (Food Allergy) 07/2023 - 01/2021
2	Neoplasms (Cancer) 02/2023 - 09/2022
2	Bites and Stings (Sting) 09/2019 - 08/2019
2	Persistent Infection 02/2010 - 06/2005
1	Zoonoses 12/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2022
1	Thrombosis (Thrombus) 09/2022
1	Myasthenia Gravis 09/2022
1	Immediate Hypersensitivity 01/2022
1	Urticaria (Hives) 01/2022
1	Aspergillosis 01/2022

Drug/Important Bio-Agent (IBA)

80	VaccinesIBA 04/2024 - 03/2003
54	AntigensIBA 11/2023 - 10/2002
48	Proteins (Proteins, Gene)FDA Link 07/2023 - 02/2003
21	Immunoglobulin E (IgE)IBA 12/2023 - 10/2015
20	AntibodiesIBA 07/2023 - 02/2003
13	AcaricidesIBA 01/2023 - 08/2003
12	CarbohydratesIBA 01/2022 - 10/2015
11	Glycoproteins (Glycoprotein)IBA 07/2023 - 07/2008
10	Membrane Proteins (Integral Membrane Proteins)IBA 05/2023 - 12/2002
9	ProteomeIBA 10/2023 - 01/2015
9	Immunoglobulin G (IgG)IBA 11/2022 - 10/2013
9	Immunoglobulin M (IgM)IBA 01/2021 - 10/2015
9	Arthropod ProteinsIBA 04/2019 - 06/2005
7	Polysaccharides (Glycans)IBA 07/2023 - 04/2020
6	tert-butylserineIBA 03/2024 - 12/2017
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2012
6	Messenger RNA (mRNA)IBA 01/2019 - 09/2007
5	GlycolipidsIBA 07/2023 - 01/2020
5	Recombinant ProteinsIBA 03/2011 - 02/2003
4	CytokinesIBA 10/2022 - 01/2013
4	tick subolesinIBA 01/2022 - 03/2011
4	RNA (Ribonucleic Acid)IBA 05/2021 - 03/2006
4	Peptides (Polypeptides)IBA 01/2021 - 08/2005
3	OligosaccharidesIBA 01/2022 - 04/2020
3	Complement System Proteins (Complement)IBA 07/2020 - 10/2013
3	Amino Acids FDA Link 01/2017 - 03/2004
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 12/2015
3	Inactivated VaccinesIBA 02/2010 - 10/2002
2	coenzyme Q10 (CoQ10)IBA 10/2023 - 02/2023
2	NF-kappa B (NF-kB)IBA 02/2023 - 01/2013
2	Prealbumin (Transthyretin)IBA 02/2023 - 09/2022
2	Blood Proteins (Serum Proteins)IBA 02/2023 - 01/2021
2	EpitopesIBA 01/2023 - 01/2021
2	Environmental Pollutants (Pollutants, Environmental)IBA 12/2022 - 10/2022
2	Immunoglobulins (Immunoglobulin)IBA 09/2022 - 04/2020
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2022 - 01/2019
2	GelatinIBA 01/2022 - 10/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 07/2002
2	Salivary Proteins and PeptidesIBA 01/2021 - 01/2018
2	InflammasomesIBA 01/2021 - 07/2020
2	Blood Group Antigens (Blood Groups)IBA 01/2020 - 01/2019
2	Cetuximab (Erbitux)FDA Link 04/2019 - 10/2015
2	DefensinsIBA 01/2018 - 12/2008
2	PorinsIBA 07/2016 - 01/2015
2	NucleotidesIBA 11/2015 - 05/2007
2	Silk FDA Link 01/2014 - 12/2013
2	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 03/2006
2	nucleotidaseIBA 11/2005 - 08/2005
2	Merozoite Surface Protein 1 (MSA1)IBA 03/2004 - 02/2003
1	mRNA VaccinesIBA 04/2024
1	Dihydrotachysterol (AT 10)IBA 01/2024
1	Phosphates (Orthophosphate)IBA 07/2023
1	Matrix Metalloproteinases (MMPs)IBA 02/2023
1	C-Reactive ProteinIBA 02/2023
1	Metalloproteases (Metalloproteinases)IBA 02/2023
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 02/2023
1	Serum AlbuminIBA 02/2023
1	Transferrin (beta 2 Transferrin)IBA 02/2023
1	PrebioticsIBA 02/2023
1	AcidsIBA 01/2023
1	Vehicle Emissions (Emissions, Vehicle)IBA 10/2022
1	AutoantibodiesIBA 09/2022
1	Keratin-10IBA 09/2022
1	SerpinsIBA 09/2022
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Antivenins (Antivenoms)IBA 01/2022

Therapy/Procedure

2	Therapeutics 01/2022 - 11/2009
1	Precision Medicine 04/2024
1	Oral Administration 01/2022